Bellevue Funds (Lux) - Diversified Healthcare U2 CHF - Accumulating/  LU2441707812  /

Fonds
NAV6/13/2025 Chg.-0.8600 Type of yield Investment Focus Investment company
109.8100CHF -0.78% reinvestment Equity Worldwide Waystone M.Co.(Lux) 

Investment strategy

The fund aims to achieve capital growth in the long term by investing in global healthcare securites. The Fund invests at least two thirds of the net assets of Bellevue Diversified Healthcare in a portfolio of carefully chosen shares and other equity securities of companies in the biotechnology industry or companies whose main activity involves holding investments in such companies or financing such companies and that have their registered office or carry out the majority of their economic activity in recognised countries. Without restricting the scope of the term "healthcare", the healthcare sector includes companies from the pharmaceutical, medical technology, biotechnology and related sectors. This includes in particular companies that create, develop, utilise, market and/or sell processes, methods, technologies, products or services used for diagnostic and therapeutic purposes in humans and animals, as well as entities primarily engaged in investing in or financing such companies. In addition, the Company may invest up to one third of the net assets of Bellevue Diversified Healthcare in carefully selected shares and other equity securities from other companies that have their registered office or carry out the majority of their economic activity in recognised countries, or in fixed-income or floating-rate securities, convertible bonds and bonds with warrants from issuers from recognised countries.
 

Investment goal

The fund aims to achieve capital growth in the long term by investing in global healthcare securites.
 

Master data

Type of yield: reinvestment
Funds Category: Equity
Region: Worldwide
Branch: Sector Health / Pharma
Benchmark: MSCI World Healthcare
Business year start: 7/1
Last Distribution: -
Depository bank: CACEIS Investor Services Bank
Fund domicile: Luxembourg
Distribution permission: Austria, Germany, Switzerland, Czech Republic
Fund manager: Dr.TerenceMcManus
Fund volume: 22.68 mill.  USD
Launch date: 3/31/2022
Investment focus: -

Conditions

Issue surcharge: 5.00%
Max. Administration Fee: 0.60%
Minimum investment: 50,000,000.00 CHF
Deposit fees: -
Redemption charge: 0.00%
Key Investor Information: Download (Print version)
 

Investment company

Funds company: Waystone M.Co.(Lux)
Address: 19, rue de Bitbourg, 1273, Luxemburg
Country: Luxembourg
Internet: www.waystone.com
 

Assets

Stocks
 
98.96%
Others
 
1.04%

Countries

United States of America
 
65.49%
Switzerland
 
9.73%
United Kingdom
 
6.19%
France
 
4.43%
Japan
 
3.82%
Denmark
 
3.41%
Ireland
 
1.48%
China
 
0.89%
Israel
 
0.56%
Netherlands
 
0.54%
Hong Kong, SAR of China
 
0.43%
Australia
 
0.37%
Finland
 
0.36%
Belgium
 
0.32%
Italy
 
0.32%
Others
 
1.66%

Branches

Pharma/Biotechnology
 
54.37%
Healthcare Appliances
 
22.24%
Healthcare Services
 
15.78%
Pharma, Wholesale
 
3.00%
Gesundheitswesen/ Informationstechnologie
 
1.88%
Grooming Products
 
1.70%
Others
 
1.03%